Calibrate’s Post

Every organization is in a different place when it comes to making decisions about covering GLP-1 medications for treating obesity. When calculating the ROI and evaluating results, it’s important to look at both cost-control and cost-saving opportunities. “The real ROI of GLP-1 medications” white paper can help guide you on how to invest and optimize budgets while supporting your employees’ health. Download now https://bit.ly/4ay3X7G Rich Gamret, FSA, MAAA

When it comes to determining whether to cover GLP-1 drugs for the treatment of obesity, each organization is in a different position. It is imperative to include both cost-control and cost-saving opportunities when computing ROI and assessing outcomes.

This World Hypertension Day, we're highlighting three projects that showcase our commitment to improving the management of high blood pressure across the lifespan. From supporting new mothers with hypertensive pregnancies through digital tools (SNAP2), to helping older adults safely reduce their blood pressure medications (OPTIMISE 2), our researchers are developing innovative solutions to this widespread health challenge. We're also evaluating the real-world effectiveness of a digital self-monitoring program (SHIP) that empowers patients to take control of their blood pressure. Central to all of our research is a focus on patient and public involvement. By partnering with patients, we ensure that our work remains relevant, sensitive to lived experiences, and ultimately more impactful. This collaborative approach has the potential to inform updated clinical guidelines, targeted interventions, and wider implementation of digital health tools. Read more at: https://lnkd.in/eHhMD76c #WorldHypertensionDay #hypertension #digitalhealth #patientengagement

Today, on World Obesity Day, let's raise awareness, promote healthy habits, and foster a supportive environment for everyone striving for better health. Submit #Manuscripts or Articles in our Journals : contactus@abacademies.org / s.rodrigues@abacademies.org Submit Manuscripts or Articles in our Journals on WhatsApp No : +44 7389 646381 #WorldObesityDay #HealthyLiving #healthinsurance #oriele #healthcare #mentalhealth #COVID19 #Medicare #Medical #linkedin @LinkedIn

#HCP: Research shows that holistic care can lead to better health outcomes for people with cardio-renal-metabolic (C-R-M) conditions, like diabetes and heart failure. Dr. Janani Rangaswami, Nephrologist and Professor of Medicine at George Washington University, provides practical tips to implement a guideline-directed, multidisciplinary approach to C-R-M health management. Learn more: https://bit.ly/3PvtYdh #KidneyWk

Let's dive into something groundbreaking: Tirzepatide, previously lauded for its weight loss and glucose control benefits, now shows promise in reducing blood pressure among those with obesity, according to the SURMOUNT-1 trial findings. Seeing blood pressure reductions up to 10.6 mmHg, Tirzepatide steps up as a potential multifaceted treatment strategy. This isn't just about a new drug; it's about reimagining patient care with more holistic, integrated treatment approaches. Are we ready to embrace this shift towards more comprehensive health management? #Hypertension #Obesity #Tirzepatide

We’re still in the early days of the GLP-1 revolution, but it’s already changing how patients and caregivers think about and treat obesity. WeightWatchers’ Dr. Spencer Nadolsky explains. Read more in What the Future: Wellness. https://lnkd.in/gDfBEAYz Be sure to also join us for our deep dive webinar on April 9 https://lnkd.in/g6qD2qDY

We’re still in the early days of the GLP-1 revolution, but it’s already changing how patients and caregivers think about and treat obesity. WeightWatchers’ Dr. Spencer Nadolsky explains. Read more in What the Future: Wellness. https://lnkd.in/ggCrKtSq Be sure to also join us for our deep dive webinar on April 9 https://lnkd.in/g4bDVxwe

We’re still in the early days of the GLP-1 revolution, but it’s already changing how patients and caregivers think about and treat obesity. WeightWatchers’ Dr. Spencer Nadolsky explains. Read more in What the Future: Wellness. https://lnkd.in/eEKdA5UE Be sure to also join us for our deep dive webinar on April 9 https://lnkd.in/eETQde2b

We are pleased to share an obesity taxonomy EASO recently developed using a Delphi process. This taxonomy is important for patients and health practitioners across Europe and will assist policy-makers in better understanding and discussing obesity. 🗣 Why Words Matter 🗣 Accurate framing and consistent terminology are vital for: -Ensuring accurate diagnosis -Effective treatment -Consistent research -Clear communication -Informed policy-making -Improved patient outcomes Read more here: https://lnkd.in/eyPfvpVK